A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

BACKGROUND: Peripheral vascular disease of the lower extremities comprises a clinical spectrum that extends from no symptoms to presentation with critical limb ischemia (CLI). Bone marrow derived Mesenchymal Stem Cells (BM- MSCs) may ameliorate the consequences of CLI due to their combinatorial pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Pawan K, Chullikana, Anoop, Parakh, Rajiv, Desai, Sanjay, Das, Anjan, Gottipamula, Sanjay, Krishnamurthy, Sagar, Anthony, Naveen, Pherwani, Arun, Majumdar, Anish S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688296/
https://www.ncbi.nlm.nih.gov/pubmed/23758736
http://dx.doi.org/10.1186/1479-5876-11-143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688296/
https://www.ncbi.nlm.nih.gov/pubmed/23758736
http://dx.doi.org/10.1186/1479-5876-11-143

Ejemplares similares